How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code LRG: Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
45 clearance records and 13 recall records in the covered releases, across 17 source company names and 1 product codes. Dated history runs from Mar 25, 1987 to Feb 12, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LRG · Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems | 45 | 13 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MICROSCAN MICROSTREP PLUS PANEL CEFOTAXIME (0.015 - 8 MCG/MLK063101 · LRG | Dade Behring, Inc. | 510(k) | Nov 1, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL MEROPENEM (0.03-4MCG/ML)K063065 · LRG | Dade Behring, Inc. | 510(k) | Oct 27, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL ERYTHROMYCIN (0.015 TO 2 MCG/ML)K062375 · LRG | Dade Behring, Inc. | 510(k) | Oct 26, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL CEFUROXIME (0.12-8 MCG/ML)K063053 · LRG | Dade Behring, Inc. | 510(k) | Oct 26, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL CEFTRIAXONE (0.015-8MCG/ML)K063064 · LRG | Dade Behring, Inc. | 510(k) | Oct 26, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL TETRACYCLINE (0.006 TO 16 MCG/ML)K062923 · LRG | Dade Behring, Inc. | 510(k) | Oct 13, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL AMPICILLIN (0.013 - 16 MCG/ML)K062927 · LRG | Dade Behring, Inc. | 510(k) | Oct 12, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL AZITHROMYCINK062585 · LRG | Dade Behring, Inc. | 510(k) | Sep 19, 2006FDA decision date |
| MICROSTREP PLUS PANEL AMOXICILLIN/CLAVULANIC ACIDK062596 · LRG | Dade Behring, Inc. | 510(k) | Sep 19, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL VANCOMYCIN (0.06 - 8 MCG/ML)K062290 · LRG | Dade Behring, Inc. | 510(k) | Sep 1, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANEL CHLORAMPHENICOL (1 TO 32 MCG/ML)K062293 · LRG | Dade Behring, Inc. | 510(k) | Aug 24, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANELK061872 · LRG | Dade Behring, Inc. | 510(k) | Aug 23, 2006FDA decision date |
| MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCIN (0.25 - 16UG/ML)K062179 · LRG | Dade Behring, Inc. | 510(k) | Aug 23, 2006FDA decision date |
| MICROSCAN MICROSTREP PLUS PANELK062276 · LRG | Dade Behring, Inc. | 510(k) | Aug 23, 2006FDA decision date |
| SENSITITRE 18-24 HOURS SUSCEPTIBILITY PLATESK053243 · LRG | Trek Diagnostic Systems, Inc. | 510(k) | Jan 20, 2006FDA decision date |
| MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCINK050043 · LRG | Dade Behring, Inc. | 510(k) | Mar 29, 2005FDA decision date |
| MICROSCAN DRIED GRAM NEGATIVE MIC/COMBO PANELS AMOXICILLIN/K. CLAVULANATEK050585 · LRG | Dade Behring, Inc. | 510(k) | Mar 18, 2005FDA decision date |
| MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH DAPTOMYCIN (0.03 - 16 MCG/ML)K043545 · LRG | Dade Behring, Inc. | 510(k) | Feb 17, 2005FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELSK041150 · LRG | Dade Behring, Inc. | 510(k) | Jul 22, 2004FDA decision date |
| MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS (GEMIFLOXACIN)K033948 · LRG | Dade Behring, Inc. | 510(k) | Mar 1, 2004FDA decision date |
| MICROSCAN DRIED GRAM NEGATIVE MIC/COMBO PANELS , ESBL SCREENK981199 · LRG | Dade Microscan, Inc. | 510(k) | Nov 18, 1998FDA decision date |
| ALAMAR ANTIBIOTIC SUSCEPTIBILITYK941425 · LRG | Alamar Biosciences Laboratory, Inc. | 510(k) | Dec 15, 1994FDA decision date |
| READARK930478 · LRG | Alamar Biosciences, Inc. | 510(k) | Oct 22, 1993FDA decision date |
| SYNERGY SCREEN TEST, MODIFICATIONK921977 · LRG | Baxter Healthcare Corp | 510(k) | Oct 12, 1993FDA decision date |
| READARK925951 · LRG | Alamar Biosciences Laboratory, Inc. | 510(k) | Aug 31, 1993FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.